Product Description

SSR9009 (STENABOLIC) Pharmaqo, commonly referred to as Stenabolic, is a synthetic research compound that has gained strong interest within metabolic and performance-related research communities. As a Rev-Erb agonist, SSR9009 (STENABOLIC) o is studied for its potential influence on metabolic activity, energy expenditure, circadian rhythm regulation, and inflammatory response.

By targeting Rev-Erb proteins, SSR9009 (STENABOLIC) may help regulate genes associated with lipid metabolism, glucose balance, and overall energy usage. This unique mechanism has made it a popular compound for research focused on fat metabolism, endurance support, and metabolic efficiency.

Many researchers are drawn to SSR9009  due to its potential to promote enhanced fat oxidation, improved stamina, and optimized metabolic pathways. Its ability to influence circadian rhythm genes also makes it a compound of interest for studies related to sleep-wake cycles and recovery processes.

While SSR9009 (STENABOLIC) has shown promising results in animal-based research models, comprehensive human clinical data remains limited. As such, it is commonly sold for research purposes only and is not approved for human consumption by major regulatory bodies.

---

Mechanism of Action

SSR9009 (STENABOLIC) works by activating Rev-Erb receptors, which play a key role in:

• Regulating circadian rhythm genes

• Controlling lipid and glucose metabolism

• Increasing mitochondrial activity

• Supporting energy expenditure

This pathway is believed to encourage the body to rely more on fat as a fuel source, potentially supporting endurance and metabolic performance in research settings.

---

Key Features

• High-quality SSR9009 (STENABOLIC) formulation

• Rev-Erb agonist for metabolic research

• Studied for fat metabolism and endurance pathways

• Supports circadian rhythm-related research

• Trusted Pharmaqo laboratory-grade product

• Intended for research use only

---

Ingredients

• Active Ingredient: SSR9009 (Stenabolic)

• Other Ingredients: Pharmaceutical-grade carrier and stabilization agents (depending on formulation)

---

Potential Research Benefits

• May support increased endurance and stamina

• Studied for enhanced fat oxidation

• Potential metabolic rate support

• May assist with inflammation-related research

• Possible influence on lipid and glucose metabolism

• Circadian rhythm regulation research applications

---

Facts About SSR9009 (STENABOLIC) Pharmaqo

SSR9009 (STENABOLIC) is recognized as a Rev-ErbA agonist that may impact internal biological clocks and metabolic systems. This makes it a popular compound in studies involving:

• Energy utilization

• Body composition pathways

• Exercise endurance research

• Recovery-related metabolic processes